Medivolve Inc. (MEDVF)
USD 0.01
(133.33%)
USD 0.01
(133.33%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 686.45 Thousand CAD | -98.15% |
| 2022 | 37.17 Million CAD | -57.18% |
| 2021 | 86.82 Million CAD | 5783.44% |
| 2020 | 1.47 Million CAD | 1070.21% |
| 2019 | -152.1 Thousand CAD | -962.13% |
| 2018 | 17.64 Thousand CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | -100.0% |
| 2007 | 6175.00 CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 288.78 Thousand CAD | 12.8% |
| 2023 Q3 | 182.62 Thousand CAD | -5.65% |
| 2023 FY | 686.45 Thousand CAD | -98.15% |
| 2023 Q4 | 256.01 Thousand CAD | 40.18% |
| 2023 Q1 | 1.43 Million CAD | -70.49% |
| 2023 Q2 | 193.55 Thousand CAD | -86.49% |
| 2022 Q4 | 4.85 Million CAD | -25.8% |
| 2022 Q3 | 6.54 Million CAD | -27.96% |
| 2022 Q2 | 9.08 Million CAD | -45.59% |
| 2022 FY | 37.17 Million CAD | -57.18% |
| 2022 Q1 | 16.69 Million CAD | -64.15% |
| 2021 FY | 86.82 Million CAD | 5783.44% |
| 2021 Q1 | 11.24 Million CAD | 638.5% |
| 2021 Q2 | 3.74 Million CAD | -66.73% |
| 2021 Q3 | 25.26 Million CAD | 575.17% |
| 2021 Q4 | 46.56 Million CAD | 84.3% |
| 2020 Q4 | 1.52 Million CAD | 1719.5% |
| 2020 FY | 1.47 Million CAD | 1070.21% |
| 2020 Q1 | - CAD | 100.0% |
| 2020 Q2 | 209.52 Thousand CAD | 0.0% |
| 2020 Q3 | -94.04 Thousand CAD | -144.89% |
| 2019 Q3 | -150.49 Thousand CAD | -2240.1% |
| 2019 FY | -152.1 Thousand CAD | -962.13% |
| 2019 Q1 | 2949.00 CAD | -83.29% |
| 2019 Q2 | 7032.00 CAD | 138.45% |
| 2019 Q4 | -152.1 Thousand CAD | -1.07% |
| 2018 Q4 | 17.64 Thousand CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 FY | 17.64 Thousand CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 100.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2008 Q1 | 2017.00 CAD | -67.34% |
| 2008 Q4 | -5479.00 CAD | -340.52% |
| 2008 Q3 | 2278.00 CAD | 92.4% |
| 2008 FY | - CAD | -100.0% |
| 2008 Q2 | 1184.00 CAD | -41.3% |
| 2007 Q1 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2007 Q4 | 6175.00 CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 FY | 6175.00 CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| 2006 Q2 | - CAD | 0.0% |
| 2006 Q4 | - CAD | 0.0% |
| 2006 Q1 | - CAD | 0.0% |
| 2006 Q3 | - CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | 24.814% |
| Arrayit Corporation | 4.37 Million USD | 84.318% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | 97.345% |
| Bioqual, Inc. | 58.59 Million USD | 98.828% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | 95.512% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 99.991% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | 89.217% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | 34.723% |
| Interpace Biosciences, Inc. | 40.21 Million USD | 98.293% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | -53.397% |
| InVitro International | 792.62 Thousand USD | 13.396% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | 93.833% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | 90.498% |
| NovelStem International Corp. | 12 Thousand USD | -5620.425% |
| Optigenex Inc. | 465.97 Thousand USD | -47.317% |
| PharmChem, Inc. | 6.01 Million USD | 88.583% |
| Proteome Sciences plc | 6.4 Million USD | 89.275% |
| Response Genetics, Inc | 18.04 Million USD | 96.195% |
| Rennova Health, Inc. | 13.03 Million USD | 94.734% |
| RushNet, Inc. | 1.78 Million USD | 61.605% |
| ScreenPro Security Inc. | 1.91 Million USD | 64.137% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | 81.912% |
| Todos Medical Ltd. | 7.69 Million USD | 91.079% |